ScienceNanotherapy may reduce fibrosis and improve cancer immunotherapy response
A paper in Science describes senescence-directed nanotherapy that it says reduces fibrosis and overcomes immune exclusion in cancer.
TLDR
Science reports that targeting senescence decreases fibrosis and boosts cancer cells’ response to immunotherapy. Its research summary identifies senescent-like cells as drivers of fibrosis and describes how fibrotic changes create immune-suppressing environments that impair organ function and limit immunotherapy response in cancer.
Nanotherapy may reduce fibrosis and improve cancer immunotherapy response
A paper in Science describes senescence-directed nanotherapy that it says reduces fibrosis and overcomes immune exclusion in cancer.
TLDR
Science reports that targeting senescence decreases fibrosis and boosts cancer cells’ response to immunotherapy. Its research summary identifies senescent-like cells as drivers of fibrosis and describes how fibrotic changes create immune-suppressing environments that impair organ function and limit immunotherapy response in cancer.
